Cargando…
Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations
BACKGROUND: Pediatric antiretroviral therapy (ART) has been shown to substantially reduce morbidity and mortality in HIV-infected infants and children. To accurately project program costs, analysts need accurate estimations of antiretroviral drug (ARV) costs for children. However, the costing of ped...
Autores principales: | Doherty, Kathleen, Essajee, Shaffiq, Penazzato, Martina, Holmes, Charles, Resch, Stephen, Ciaranello, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021070/ https://www.ncbi.nlm.nih.gov/pubmed/24885453 http://dx.doi.org/10.1186/1472-6963-14-201 |
Ejemplares similares
-
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015) -
HIV Testing for Children in Resource-Limited Settings: What Are We Waiting For?
por: Kellerman, Scott, et al.
Publicado: (2010) -
Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021) -
A Global Research Agenda for Pediatric HIV
por: Penazzato, Martina, et al.
Publicado: (2018) -
Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus
por: Desmonde, Sophie, et al.
Publicado: (2019)